SCHEMBL14038378

SCHEMBL14038378

CCCCO[C@@H]1C(C)O[C@@H](c2ccc3c(N)ncnn23)[C@]1(C)OCCCC

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.31
▸ DOT1L Q8TEK3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14140989 0.88 — —
SCHEMBL9912348 0.87 DOT1L (0.30) DOT1L
SCHEMBL11924463 0.87 DOT1L (0.30) DOT1L
SCHEMBL12305478 0.86 — —
SCHEMBL14140990 0.77 — —
SCHEMBL13532237 0.76 — —
SCHEMBL15682803 0.74 POLRMT (0.39) POLRMT
SCHEMBL16710421 0.74 POLRMT (0.36) POLRMTDOT1L
SCHEMBL12306914 0.73 — —
SCHEMBL9912351 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008141079-A1 TETRAHYDROFURO [3 4-D] DIOXOLANE COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS AND CANCER BIOCRYST PHARMACEUTICALS, INC. (US) 2008-11-20 — — WO disclosed
Send feedback